68Ga-DOTATOC PET/CT 鉴别脑膜瘤与硬脑膜转移
一例77岁乳腺癌女性患者MRI发现两处性质不明的硬脑膜强化灶,鉴别诊断包括乳腺癌转移与脑膜瘤。68Ga-DOTATOC PET/CT显示颞部病灶高摄取、归类为脑膜瘤,大脑镰病灶几乎无摄取、提示脑转移;术后病理分别证实为SSTR2A高表达的脑膜瘤与SSTR2A无明显表达的乳腺癌转移。
要点
- 68Ga-DOTATOC PET/CT可帮助鉴别性质不明的硬脑膜病灶。
- 高摄取倾向脑膜瘤,几乎无摄取提示硬脑膜转移。
- 病理SSTR2A表达与68Ga-DOTATOC摄取结果一致。
核心结论
- 68Ga-DOTATOC PET是评估性质不明硬脑膜病灶的有力影像手段。
研究设计与样本
- 单例病例报告:77岁乳腺癌女性,MRI见2处性质不明的硬脑膜强化灶。
主要发现
- 68Ga-DOTATOC PET/CT示颞部病灶高摄取并归类为脑膜瘤。
- 大脑镰病灶几乎无68Ga-DOTATOC摄取,提示脑转移。
- 术后病理示颞部病灶为脑膜瘤且SSTR2A明显表达。
- 大脑镰病灶为乳腺癌转移且无明显SSTR2A表达。
临床怎么用
- 对MRI性质不明的硬脑膜病灶,可考虑68Ga-DOTATOC PET/CT辅助鉴别脑膜瘤与转移。
局限性
- 为单例病例报告,结论需更多病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 77-year-old woman with history of breast cancer presented with 2 unclear dural contrast-enhancing lesions on MRI; differential diagnoses were breast cancer metastases and meningiomas. On Ga-DOTATOC PET/CT, the temporal lesion showed high uptake and was classified as meningioma, whereas the lesion at the falx showed barely any Ga-DOTATOC uptake uncharacteristic for meningioma and suggestive for a brain metastasis. After resection, histological specimens from the temporal lesion showed meningioma tissue with distinct SSTR2A expression, whereas the falx lesion revealed a breast cancer metastasis without significant SSTR2A expression. Therefore, Ga-DOTATOC PET represents a powerful imaging modality for the evaluation of unclear dural lesions.
引用
- Unterrainer M, Ruf V, Ilhan H, et al. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases. Clin Nucl Med. 2019. PMID: 30829858. doi:10.1097/RLU.0000000000002513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。